We demonstrate that elderly KL-VShet carriers with elevated Aβ burden, i.e., the earliest primary AD pathology, exhibited lower tau-PET levels and tau-PET annual change rates when compared to those in KL-VShetnon-carriers. This evidence concerns the gene MAPT and Alzheimer disease.